Literature DB >> 22689579

The Pseudo signal peptide of the corticotropin-releasing factor receptor type 2A prevents receptor oligomerization.

Anke Teichmann1, Claudia Rutz, Annika Kreuchwig, Gerd Krause, Burkhard Wiesner, Ralf Schülein.   

Abstract

N-terminal signal peptides mediate the interaction of native proteins with the translocon complex of the endoplasmic reticulum membrane and are cleaved off during early protein biogenesis. The corticotropin-releasing factor receptor type 2a (CRF(2(a))R) possesses an N-terminal pseudo signal peptide, which represents a so far unique domain within the large protein family of G protein-coupled receptors (GPCRs). In contrast to a conventional signal peptide, the pseudo signal peptide remains uncleaved and consequently forms a hydrophobic extension at the N terminus of the receptor. The functional consequence of the presence of the pseudo signal peptide is not understood. Here, we have analyzed the significance of this domain for receptor dimerization/oligomerization in detail. To this end, we took the CRF(2(a))R and the homologous corticotropin-releasing factor receptor type 1 (CRF(1)R) possessing a conventional cleaved signal peptide and conducted signal peptide exchange experiments. Using single cell and single molecule imaging methods (fluorescence resonance energy transfer and fluorescence cross-correlation spectroscopy, respectively) as well as biochemical experiments, we obtained two novel findings; we could show that (i) the CRF(2(a))R is expressed exclusively as a monomer, and (ii) the presence of the pseudo signal peptide prevents its oligomerization. Thus, we have identified a novel functional domain within the GPCR protein family, which plays a role in receptor oligomerization and which may be useful to study the functional significance of this process in general.

Mesh:

Substances:

Year:  2012        PMID: 22689579      PMCID: PMC3411068          DOI: 10.1074/jbc.M112.360594

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  45 in total

1.  A novel spliced variant of the type 1 corticotropin-releasing hormone receptor with a deletion in the seventh transmembrane domain present in the human pregnant term myometrium and fetal membranes.

Authors:  D K Grammatopoulos; Y Dai; H S Randeva; M A Levine; E Karteris; A J Easton; E W Hillhouse
Journal:  Mol Endocrinol       Date:  1999-12

2.  Oligomerization of mu- and delta-opioid receptors. Generation of novel functional properties.

Authors:  S R George; T Fan; Z Xie; R Tse; V Tam; G Varghese; B F O'Dowd
Journal:  J Biol Chem       Date:  2000-08-25       Impact factor: 5.157

Review 3.  Fluorescence correlation spectroscopy measures molecular transport in cells.

Authors:  E L Elson
Journal:  Traffic       Date:  2001-11       Impact factor: 6.215

4.  Simultaneous two-photon excitation of distinct labels for dual-color fluorescence crosscorrelation analysis.

Authors:  K G Heinze; A Koltermann; P Schwille
Journal:  Proc Natl Acad Sci U S A       Date:  2000-09-12       Impact factor: 11.205

Review 5.  Ultrasensitive investigations of biological systems by fluorescence correlation spectroscopy.

Authors:  Elke Haustein; Petra Schwille
Journal:  Methods       Date:  2003-02       Impact factor: 3.608

6.  Chemokine receptor homo- or heterodimerization activates distinct signaling pathways.

Authors:  M Mellado; J M Rodríguez-Frade; A J Vila-Coro; S Fernández; A Martín de Ana; D R Jones; J L Torán; C Martínez-A
Journal:  EMBO J       Date:  2001-05-15       Impact factor: 11.598

Review 7.  Roles of G-protein-coupled receptor dimerization.

Authors:  Sonia Terrillon; Michel Bouvier
Journal:  EMBO Rep       Date:  2004-01       Impact factor: 8.807

8.  Regulation of the coupling to different G proteins of rat corticotropin-releasing factor receptor type 1 in human embryonic kidney 293 cells.

Authors:  Doreen Wietfeld; Nadja Heinrich; Jens Furkert; Klaus Fechner; Michael Beyermann; Michael Bienert; Hartmut Berger
Journal:  J Biol Chem       Date:  2004-07-12       Impact factor: 5.157

9.  Coexpression of delta-opioid receptors with micro receptors in GH3 cells changes the functional response to micro agonists from inhibitory to excitatory.

Authors:  Andrew C Charles; Natalya Mostovskaya; Kathleen Asas; Christopher J Evans; Megan L Dankovich; Tim G Hales
Journal:  Mol Pharmacol       Date:  2003-01       Impact factor: 4.436

10.  Properties of N-terminal tails in G-protein coupled receptors: a statistical study.

Authors:  E Wallin; G von Heijne
Journal:  Protein Eng       Date:  1995-07
View more
  13 in total

1.  The specific monomer/dimer equilibrium of the corticotropin-releasing factor receptor type 1 is established in the endoplasmic reticulum.

Authors:  Anke Teichmann; Arthur Gibert; André Lampe; Paul Grzesik; Claudia Rutz; Jens Furkert; Jan Schmoranzer; Gerd Krause; Burkhard Wiesner; Ralf Schülein
Journal:  J Biol Chem       Date:  2014-06-25       Impact factor: 5.157

2.  GluA1 signal peptide determines the spatial assembly of heteromeric AMPA receptors.

Authors:  Xue-Yan He; Yan-Jun Li; Chakrapani Kalyanaraman; Li-Li Qiu; Chen Chen; Qi Xiao; Wen-Xue Liu; Wei Zhang; Jian-Jun Yang; Guiquan Chen; Matthew P Jacobson; Yun Stone Shi
Journal:  Proc Natl Acad Sci U S A       Date:  2016-09-06       Impact factor: 11.205

3.  Evidence of G-protein-coupled receptor and substrate transporter heteromerization at a single molecule level.

Authors:  Jana Fischer; Gunnar Kleinau; Claudia Rutz; Denise Zwanziger; Noushafarin Khajavi; Anne Müller; Maren Rehders; Klaudia Brix; Catherine L Worth; Dagmar Führer; Heiko Krude; Burkhard Wiesner; Ralf Schülein; Heike Biebermann
Journal:  Cell Mol Life Sci       Date:  2017-12-30       Impact factor: 9.261

Review 4.  Novel insights on thyroid-stimulating hormone receptor signal transduction.

Authors:  Gunnar Kleinau; Susanne Neumann; Annette Grüters; Heiko Krude; Heike Biebermann
Journal:  Endocr Rev       Date:  2013-05-03       Impact factor: 19.871

5.  Dopamine D1 and corticotrophin-releasing hormone type-2α receptors assemble into functionally interacting complexes in living cells.

Authors:  J Fuenzalida; P Galaz; K A Araya; P G Slater; E H Blanco; J M Campusano; F Ciruela; K Gysling
Journal:  Br J Pharmacol       Date:  2014-12       Impact factor: 8.739

6.  Actin cytoskeleton-dependent regulation of corticotropin-releasing factor receptor heteromers.

Authors:  Burcu Hasdemir; Shilpi Mahajan; Juan Oses-Prieto; Shreya Chand; Michael Woolley; Alma Burlingame; Dimitris K Grammatopoulos; Aditi Bhargava
Journal:  Mol Biol Cell       Date:  2017-07-12       Impact factor: 4.138

7.  Molecular Modeling of Structures and Interaction of Human Corticotropin-Releasing Factor (CRF) Binding Protein and CRF Type-2 Receptor.

Authors:  Paula G Slater; Sebastian E Gutierrez-Maldonado; Katia Gysling; Carlos F Lagos
Journal:  Front Endocrinol (Lausanne)       Date:  2018-02-20       Impact factor: 5.555

Review 8.  Endocrinology and the brain: corticotropin-releasing hormone signaling.

Authors:  Carolina Inda; Natalia G Armando; Paula A Dos Santos Claro; Susana Silberstein
Journal:  Endocr Connect       Date:  2017-07-14       Impact factor: 3.335

9.  Receptor oligomerization: from early evidence to current understanding in class B GPCRs.

Authors:  Stephanie Y L Ng; Leo T O Lee; Billy K C Chow
Journal:  Front Endocrinol (Lausanne)       Date:  2013-01-04       Impact factor: 5.555

Review 10.  Corticotropin-Releasing Factor Family: A Stress Hormone-Receptor System's Emerging Role in Mediating Sex-Specific Signaling.

Authors:  Lahari Vuppaladhadiam; Cameron Ehsan; Meghana Akkati; Aditi Bhargava
Journal:  Cells       Date:  2020-03-31       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.